206 related articles for article (PubMed ID: 8924358)
1. Cytokines in rheumatic diseases.
Miller LC
Biotherapy; 1994; 8(2):99-111. PubMed ID: 8924358
[TBL] [Abstract][Full Text] [Related]
2. Biologic activities of interleukin-1 relevant to rheumatic diseases.
Miller LC; Dinarello CA
Pathol Immunopathol Res; 1987; 6(1):22-36. PubMed ID: 3128783
[TBL] [Abstract][Full Text] [Related]
3. Cytokines in the rheumatic diseases.
Arend WP; Gabay C
Rheum Dis Clin North Am; 2004 Feb; 30(1):41-67, v-vi. PubMed ID: 15061568
[TBL] [Abstract][Full Text] [Related]
4. Chemokines in rheumatic diseases.
Szekanecz Z; Szücs G; Szántó S; Koch AE
Curr Drug Targets; 2006 Jan; 7(1):91-102. PubMed ID: 16454702
[TBL] [Abstract][Full Text] [Related]
5. B lymphocyte cytokines and rheumatic autoimmune disease.
Youinou P; Taher TE; Pers JO; Mageed RA; Renaudineau Y
Arthritis Rheum; 2009 Jul; 60(7):1873-80. PubMed ID: 19565509
[No Abstract] [Full Text] [Related]
6. Tobacco smoking and autoimmune rheumatic diseases.
Harel-Meir M; Sherer Y; Shoenfeld Y
Nat Clin Pract Rheumatol; 2007 Dec; 3(12):707-15. PubMed ID: 18037930
[TBL] [Abstract][Full Text] [Related]
7. Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment.
Soltész P; Kerekes G; Dér H; Szücs G; Szántó S; Kiss E; Bodolay E; Zeher M; Timár O; Szodoray P; Szegedi G; Szekanecz Z
Autoimmun Rev; 2011 May; 10(7):416-25. PubMed ID: 21281743
[TBL] [Abstract][Full Text] [Related]
8. Proinflammatory cytokines (IL-12 and IL-18) in immune rheumatic diseases: relation with disease activity and autoantibodies production.
Mosaad YM; Metwally SS; Auf FA; AbdEL-Samee ER; el-Deek B; Limon NI; el-Chennawi FA
Egypt J Immunol; 2003; 10(2):19-26. PubMed ID: 15719608
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-32 as a biomarker in rheumatic diseases: A narrative review.
Kwon OC; Park MC; Kim YG
Front Immunol; 2023; 14():1140373. PubMed ID: 36875066
[TBL] [Abstract][Full Text] [Related]
10. Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases.
Distler JH; Beyer C; Schett G; Lüscher TF; Gay S; Distler O
Arthritis Rheum; 2009 Nov; 60(11):3168-79. PubMed ID: 19877034
[No Abstract] [Full Text] [Related]
11. Mechanisms of Disease: the role of high-mobility group protein 1 in the pathogenesis of inflammatory arthritis.
Jiang W; Pisetsky DS
Nat Clin Pract Rheumatol; 2007 Jan; 3(1):52-8. PubMed ID: 17203009
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis and mechanisms of inflammation in the childhood rheumatic diseases.
Jarvis JN
Curr Opin Rheumatol; 1998 Sep; 10(5):459-67. PubMed ID: 9746862
[TBL] [Abstract][Full Text] [Related]
13. Immune complex-mediated rheumatic diseases: the evidence and the enigmas.
Williams RC
Postgrad Med; 1980 Nov; 68(5):124-31, 133. PubMed ID: 6448996
[TBL] [Abstract][Full Text] [Related]
14. Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients.
Higgs BW; Zhu W; Richman L; Fiorentino DF; Greenberg SA; Jallal B; Yao Y
Int J Rheum Dis; 2012 Feb; 15(1):25-35. PubMed ID: 22324944
[TBL] [Abstract][Full Text] [Related]
15. Rheumatic diseases of children, including systemic lupus erythematosus, dermatomyositis, scleroderma, and fasciitis.
Martini A
Curr Opin Rheumatol; 1994 Sep; 6(5):518-22. PubMed ID: 7993710
[No Abstract] [Full Text] [Related]
16. Immune mechanisms in rheumatic disease.
Workman ML
Nurs Clin North Am; 2000 Mar; 35(1):175-88. PubMed ID: 10673573
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory cytokines and sickness behavior in rheumatic diseases.
Lorton D; Lubahn CL; Zautra AJ; Bellinger DL
Curr Pharm Des; 2008; 14(13):1242-60. PubMed ID: 18537649
[TBL] [Abstract][Full Text] [Related]
18. Nutrition and pediatric rheumatic diseases. Hypothesis: cytokines modulate nutritional abnormalities in rheumatic diseases.
Ostrov BE
J Rheumatol Suppl; 1992 Apr; 33():49-53. PubMed ID: 1593602
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.
Bayry J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
Nat Clin Pract Rheumatol; 2007 May; 3(5):262-72. PubMed ID: 17471245
[TBL] [Abstract][Full Text] [Related]
20. New cytokine targets in inflammatory rheumatic diseases.
Connell L; McInnes IB
Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):865-78. PubMed ID: 16980211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
